Previous Article | Next Article ![]()
Infection and Immunity, September 2000, p. 5277-5283, Vol. 68, No. 9
Department of Pathology, The Johns Hopkins
University School of Medicine,1 and
Department of Pathology, The University of Maryland School of
Medicine,2 Baltimore, Maryland; Section
of Infectious Diseases, Saint Mary's Duluth Clinic Health System,
Duluth, Minnesota3; Department of
Medicine and Epidemiology, Veterinary Medical School, University of
California, Davis, California4; and
Department of Pathology, The University of Texas Medical
Branch, Galveston, Texas5
Received 22 February 2000/Returned for modification 2 April
2000/Accepted 10 June 2000
Human granulocytic ehrlichiosis (HGE) is a potentially fatal,
tick-borne disease caused by a bacterium related or identical to
Ehrlichia phagocytophila. To identify and characterize
E. phagocytophila group-specific protein antigen genes, we
prepared and screened HGE agent and Ehrlichia equi genomic
DNA expression libraries using polyclonal equine E. equi
antibodies. Two clones, one each from HGE agent and E. equi, that were recognized specifically by antibodies to the
E. phagocytophila group ehrlichiae had complete open
reading frames of 3,693 and 3,615 nucleotides, respectively. The two
clones were 96.6% identical and predicted a protein with at least 11 tandemly repeated ankyrin motifs. Thus, the gene was named
ank (for ankyrin). When the encoded protein, named AnkA, was expressed in Escherichia coli, it was recognized by
antibodies from rabbits and mice immunized with the HGE agent, sera
from humans convalescent from HGE, and sera from horses convalescent from HGE and E. equi infection. Monospecific AnkA
antibodies reacted with proteins in HGE agent immunoblots, and AnkA
monoclonal antibodies detected cytoplasmic antigen in E. phagocytophila group bacteria and also detected antigen
associated with chromatin in infected but not uninfected HL-60 cell
cultures. These results suggest that this Ehrlichia protein
may influence host cell gene expression.
Human granulocytic ehrlichiosis
(HGE) is an emerging tick-borne infection with manifestations ranging
from no symptoms to death (1, 6, 9). Most patients are
mildly to moderately affected, with fever, headache, myalgias,
leukopenia, thrombocytopenia, and elevations in serum hepatic
transaminases. The causative microorganism, named the HGE agent, is a
member of the Ehrlichia phagocytophila group, which also
includes E. phagocytophila and Ehrlichia equi in
a tight phylogenetic cluster, probably representing a single species
(10, 25, 26).
The E. phagocytophila group has been characterized mainly
through analysis of genes encoding the 16S rRNA and the
groESL operon (2, 9, 25, 26). These genes are
highly conserved and are therefore unlikely to reveal the phylogenetic
and pathogenetic differences that could account for the diversity of
clinical findings and the diversity of mammalian hosts in ehrlichial
infection. The E. phagocytophila group has also been shown
to possess specific genes that, unlike conserved genes, can be useful
for phylogenetic comparisons among animal and human strains (4,
10). Moreover, studying the function of the proteins encoded by
species-specific genes may provide insights into the pathogenetic
potential of granulocytic ehrlichiae.
In recent months, several groups have cloned genes from the HGE agent
(14, 19, 24, 28), including a 2,244-nucleotide (nt) gene
encoding a 160-kDa protein antigen with multiple ankyrin motifs.
However, to date no function has been attributed to any of the proteins
encoded by these genes. The goals of the present work were to identify
genes specific to E. phagocytophila group ehrlichiae and to
begin elucidating their role in the intracellular infection caused by
the E. phagocytophila group ehrlichiae.
(This work was presented in part at the 13th Sesqui-Annual Meeting of
the American Society for Rickettsiology, Champion, Pa., 21 to 24 September 1997.)
Construction and screening of HGE genomic libraries.
The HGE
agent (BDS strain) and E. equi (MRK strain) were used to
experimentally infect horses. Horse blood was obtained when ehrlichial
morulae were shown by Wright staining in 50% or more of the
neutrophils. Neutrophils were then purified by dextran sedimentation,
washed in sterile phosphate-buffered saline (pH 7.4), and suspended in
0.1 M phosphate buffer, which contained 7% sucrose and 5 mM glutamine.
Ehrlichiae were isolated from the neutrophils by Renografin
(diatrizoate meglumine) density gradient centrifugation, as previously
described (4, 10).
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
ankA: an Ehrlichia
phagocytophila Group Gene Encoding a Cytoplasmic Protein Antigen
with Ankyrin Repeats
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
Characterization of two unique E. phagocytophila
group-specific clones.
One clone from the HGE agent library (named
hge-d), and one clone from the E. equi library
(named ee-o) were sequenced on both strands. Partial open
reading frames were identified in both, and complete gene sequences
were then obtained by alignment of the sequences, PCR amplification of
the flanking regions, and sequencing by gene walking. Southern blot
analysis was performed using 5 µg of DNAs from the HGE agent (Webster
strain), E. coli XLOLR, and HL-60 cells, which were digested
with PstI, BamHI, and KpnI. In
addition, HGE agent DNA was digested with EcoRI, HindIII, XhoI, and BglII. Digested
DNAs were separated by overnight electrophoresis and then transferred
onto Zeta-Probe GT (Bio-Rad, Hercules, Calif.). A 480-bp
SalI-BamHI fragment (see Fig. 2) was used to make
a 32P-labeled probe, using a DECAprime II labeling kit
(Ambion, Austin, Tex.). Hybridization was carried out overnight at
60°C in 0.25 M phosphate buffer (pH 7.2)-7% SDS-5% dextran
sulfate containing 1.5 × 106 trichloroacetic
acid-precipitable cpm of the probe per ml of hybridization buffer.
Blots were quickly washed twice in 2× SSC (1× SSC is 0.15 M NaCl plus
0.015 M sodium citrate) and then washed for 1 h at 42°C with
gentle shaking in 50 mM phosphate buffer (pH 7.2) with 5% SDS. The
blots were wrapped in plastic and exposed overnight at
70°C to
BioMax MS autoradiographic film (Eastman Kodak, Rochester, N.Y.).
Sequencing of a 444-bp ankA amplicon in various E. phagocytophila group strains. A forward primer (5'-GAGAGATGCTTATGGTAAGAC-3'), and a reverse primer (5'-CGTTCAGCCATCATTGTGAC-3') were designed to amplify a 444-bp fragment from hge-d and ee-o (see Fig. 2). PCR was performed on DNA prepared from the following samples: four human HGE agent strains (Webster, Spooner, and 96HE-97 from Wisconsin and NY-8 from New York) in HL-60 cells, one HGE agent strain (97E12 from a Minnesota dog) in HL-60 cells, one blood sample from another Minnesota dog infected with the HGE agent, one blood sample from a Spanish goat with tick-borne fever (courtesy of Philippe Brouqui), neutrophils isolated from a cow with tick-borne fever in Sweden (courtesy of Philippe Brouqui and Anneli Bjöersdorff) containing different local strains of E. phagocytophila, E. sennetsu Miyayama strain in P388D1 cells (courtesy C. of Pretzman, Ohio State Department of Health), E. risticii HRC-IL strain (ATCC VR-986) in P388D1 cells, E. chaffeensis Arkansas strain in DH82 cells (courtesy of J. Dawson, Centers for Disease Control and Prevention, Atlanta, Ga.), E. chaffeensis 91HE17 strain in DH82 cells, and E. canis Oklahoma strain in DH82 cells (courtesy J. Dawson). PCR was also performed on DNA from uninfected HL-60 cells. PCR products were evaluated for size and staining intensity by agarose gel electrophoresis, and then sequenced.
Immunologic features of AnkA. A 2.5-kb SalI-HindIII fragment comprising the ankA partial open reading frame in hge-d (devoid of promoter sequences) was subcloned into pMAL-c2 (New England Biolabs, Beverly, Mass.) to allow the expression of a fusion protein comprised of 391 amino acids (43 kDa) from the maltose-binding protein (MBP) and 520 amino acids from the product of the hge-d ankA partial open reading frame (54-kDa predicted molecular mass) (see Fig. 2). The fusion protein, named MBP-AnkA, was purified on an amylose resin column, mixed with RIBI adjuvant system (RIBI Immunochem Research, Inc., Hamilton, Mont.), and used to immunize three BALB/c mice over a period of 45 days. Murine peripheral blood and splenocytes were used to produce polyclonal and monoclonal antibodies, respectively. Polyclonal antibodies were tested for reactivity to MBP-AnkA and whole HGE agent by Western blotting (10), using sera from the mice immunized with MBP-AnkA, from a mouse that was infected with the HGE agent (BDS strain), from a rabbit immunized with the HGE agent (Webster strain), from a rabbit immunized with MBP (GIBCO/BRL, Gaithersburg, Md.), or from a nonimmunized mouse and rabbit.
Monoclonal antibodies were produced by fusing splenocytes from MBP-AnkA-immunized mice to SP2/0 cells, using a ClonaCellTM-HY hybridoma cloning kit (Stem Cell Technologies, Inc., Vancouver, British Columbia, Canada). Hybridomas that secreted antibodies reactive with whole HGE agent, as determined by immunofluorescence, were selected for further screening by protein immunoblots. Hybridomas that secreted antibodies recognizing MBP-AnkA in protein immunoblots were subcloned, and the antibodies were purified on protein G-Sepharose columns (Pharmacia, Uppsala, Sweden).Cellular localization of AnkA in the HGE agent and infected HL-60
cells.
Monoclonal antibodies to MBP-AnkA were used to define by
electron microscopy the cellular distribution of AnkA within the HGE
agent and in infected HL-60 cells. HL-60 cells were infected with HGE
agent and propagated in vitro until at least 50% of them contained
ehrlichial morulae as determined by Romanowsky staining. At that point,
approximately 2.5 × 106 HL-60 cells were prepared for
immunoelectron microscopy, as previously described (22, 23).
Ultrathin sections were reacted with a monoclonal antibody directed
against AnkA {IE3; immunoglobulin G1 kappa chain [IgG1(
)]} and
with a control antibody. Grids were then washed, dried, and reacted for
30 min at room temperature with protein A conjugated to 15-nm-diameter
colloidal gold particles (AuroProbeTM EM Protein AG15; Amersham Life
Science, Arlington Heights, Ill.), diluted 1:200 or 1:400 in 10 mM
phosphate-buffered saline. Immunostained grids were finally stained
with aqueous 2% uranyl acetate and 0.4% lead citrate and examined
using a Philips 201 electron microscope.
Nucleotide sequence accession numbers. The full-length gene sequences from the hge-d (BDS strain) and ee-o (MRK strain) clones have been deposited in GenBank under accession numbers AF047897 and AF153716, respectively.
| |
RESULTS |
|---|
|
|
|---|
Immunoreactivity of two E. phagocytophila group clones.
E. coli transformed with hge-d and
ee-o expressed proteins of 68 and 145 kDa, respectively,
that were recognized by sera from humans, horses, and dogs infected
with the HGE agent, and from horses infected with E. equi,
but not by the following sera: human and rabbit anti-E.
chaffeensis, human anti-R. rickettsii, human anti-Borrelia burgdorferi, human anti-Babesia
microti, antibodies to other Ehrlichia species or
unrelated bacteria, and normal human, horse, or rabbit sera (Fig.
1). These results indicate that
hge-d and ee-o expressed E. phagocytophila group-specific antigens.
|
Genomic features of ankA.
DNA sequencing revealed that
the hge-d and ee-o clones contained similar
partial open reading frames. A BLAST search revealed these to be 97%
identical to a clone reported by Storey et al. (GenBank accession
number AF020521) (24). The initial hge-d clone
was 5' truncated and lacked promoter sequences, whereas the
ee-o clone had full 5' promoter sequences but was truncated at the 3' end. Subsequently, the sequencing done to complete the hge-d and ee-o partial open reading frames showed
full-length genes of 3,693 and 3,615 nt, respectively, that were 96.6%
identical. The diversity was primarily due to the presence in
hge-d of two tandemly arranged 81-nt fragments, only one of
which was present in ee-o. This analysis showed that the two
genes were nearly identical, and thus they are named here
ankA (for ankyrin). Both genes had identical promoter
sequences 5' to the ATG initiator codons, including the ribosomal
binding sites and
10 (Pribnow box) and
35 regions. Translation of
the two full-length open reading frames predicted proteins of 1,205 and
1,231 amino acids, named AnkA, with predicted molecular masses of 128 and 131 kDa, respectively. The most striking feature of AnkA was the
presence of eight full ankyrin-like repeats of 33 amino acids and three
partial ankyrin-like repeats (Fig. 2B)
with a consensus sequence of -G-T-LH-AA--G-------L---G-------- (the
signature mammalian ankyrin-like sequence is
-G-TPLH-AA-GH---V/A-LL-GA-N/D----). Computer analyses showed that
AnkA does not have transmembrane regions and that it is highly
hydrophilic, suggesting the possibility that it is located within the
ehrlichial cytoplasm. Computer analysis also showed the presence of the
following motifs: one tyrosine kinase phosphorylation site (residues
367 to 374), one N-glycosylation site (residues 812 to 815), and
several protein kinase C and casein kinase II phosphorylation sites.
Four potential prokaryotic secretory signal cleavage sites were
identified at positions 631 and 632, 682 and 683, 933 and 934, and 1136 and 1137; however, no N-terminal secretory signal sequence was
identified by the method of Nakai and Kanehisa (20).
Finally, computer analysis for internal repeats showed the presence of
two identical repeats of 11 amino acids (ERPESIYADP) and two identical
and consecutive repeats of 27 amino acids
(GAEESIYEEIKDTAKGTTEVESTYTTVGA). The second 27-amino-acid repeat was missing in the predicted protein encoded by the full-length ankA gene in the MRK strain of E. equi. Digestion
of the HGE agent genomic DNA with seven restriction endonucleases
showed specific hybridization of the ankA probe
predominantly to one locus, although less intense bands were identified
at other loci in the HGE agent genome (Fig.
3).
|
|
Sequence variation of ankA in various E. phagocytophila group members.
We wished to assess whether
the diversity observed between the ankA genes was also
present among other E. phagocytophila group members from
different geographic regions. Thus, we selected a 444-bp fragment from
hge-d and ee-o and compared it to the same region
amplified from the eight additional strains described in Materials and
Methods. All of the HGE agent strains showed 100% identity, and the
E. equi MRK strain showed 99.6% identity. The E. phagocytophila strains differed from each other (97.1% identity) and differed more substantially from the HGE agent and E. equi (Table 1).
|
Immunologic features of AnkA.
The expression in E. coli of the original hge-d SalI-HindIII
fragment yielded a fusion protein of approximately 110 kDa, of which 67 kDa was derived from AnkA. When it was used as an antigen for
immunoblotting, the fusion protein was recognized by mouse polyclonal
and monoclonal antibodies to MBP-AnkA and also by rabbit polyclonal
antibodies to whole HGE agent (Fig. 4A,
lane 2). These antibodies recognized two or three major bands, with the
strongest being 110 kDa and the other migrating as a doublet at
approximately 160 kDa (Fig. 4A, lanes 1, 2, and 6).
|
AnkA is a cytoplasmic ehrlichial protein.
Murine monoclonal
antibody to MBP-AnkA readily bound to the cytoplasm, but not to
membrane and extracellular structures, of the HGE agent present within
HL-60 vacuoles (Fig. 5A). Interestingly, the antibody also bound to the chromatin of HL-60 cells infected by the
HGE agent (Fig. 5A and C) but not to that of uninfected HL-60 cells.
Finally, the antibody bound to condensed chromatin of infected and
apoptotic HL-60 cells (Fig. 5C). These results suggest that AnkA
localizes in the cytoplasm of the HGE agent and that it is also
secreted during infection of eukaryotic cells, associating with a
yet-undefined nuclear component.
|
| |
DISCUSSION |
|---|
|
|
|---|
Our hypothesis that E. phagocytophila group ehrlichiae contain species-specific protein antigens that might be critically involved in intracellular growth prompted a search in libraries of HGE agent and E. equi genomes. This resulted in the cloning from two distinct strains of a gene, called ankA that is similar to a gene previously reported (24). The analysis indicated that the gene originally reported by Storey et al. (24) lacked 1,453 nt at the 5' end, partially explaining the discrepancy between the observed 160-kDa protein and the predicted 79-kDa protein.
AnkA is a protein rich in ankyrin motifs, of approximately 160 kDa, present in native HGE agent and E. equi. The occurrence of additional protein antigens of lower molecular mass and the presence of more than a single copy in whole-genome Southern blots suggest that the encoding gene is part of a multigene family in the HGE agent genome. The role of AnkA in ehrlichial function or in pathogenesis is not known. However, some of the adaptations that allow ehrlichiae to reside within vacuoles require communication through the endocytic membrane, a function facilitated by ankyrins (8, 12, 18, 21). However, the amino acid motif analyses and the ultrastructural localization studies do not support a role for AnkA in the trafficking of the ehrlichia-containing vacuole. Aside from the ankyrin repeats, BLAST analysis of protein databases has not revealed significant identity with other proteins of known function. We cannot exclude the possibility that a cross-reactive host protein was expressed during ehrlichia infection. However, the detection of an AnkA epitope associated with host cell chromatin in infected but not uninfected cell cultures suggests a potential role in regulation or modification of host cell gene transcription.
The potential interaction of AnkA with condensed host cell chromatin is
a compelling finding, since proteins with ankyrin repeats are well
described to affect proinflammatory cytokine expression by virtue of
molecular similarities to cellular I
B and calcineurin proteins
(5, 17). The related E. chaffeensis has been
shown to inhibit proinflammatory cytokine production by preventing the
dissociation of I
B from NF-
B, thus precluding NF-
B
translocation to the nucleus (15). The identification of
AnkA in association with condensed chromatin of host cells in infected
cultures, including apoptotic cells, could suggest a role in
down-regulated expression of the cell cycle regulators PCNA, pRB, and
bcl-2 and inhibition of G1/S cell cycle transition, and
induction of apoptosis and host cell death, as described for infected
HL-60 cells by Hsieh et al. (13).
The 444-bp fragment, containing part of the region coding for the ankyrin repeats, could be detected by PCR in all North American E. phagocytophila laboratory strains and had nearly identical nucleic acid and predicted amino acid sequences; however, these differed modestly from those of E. phagocytophila strains present in geographically diverse parts of Europe, which in turn differed from each other by a similar degree. Such findings further confirm molecular, biological, and antigenic analyses indicating that E. equi, E. phagocytophila, and the HGE agent are a single, heterogeneous species (2, 7, 9, 16, 25, 26), as implied in previous phylogenetic studies (25).
Variation in the quantity of tandemly repeated units is an emerging hallmark of many bacteria, including Ehrlichia and Rickettsia spp. (3, 11, 27). The situation with AnkA is unusual in that it is a cytoplasmic protein, whereas most other tandemly repeated units in the Rickettsia and Ehrlichia genera appear to be cell surface expressed. Moreover, given the similar degrees of pathogenicity of E. equi and the HGE agent (7, 16), the 27-amino-acid repeat region is unlikely to be pathogenetically important in mammals.
In summary, we report the full-length sequence of AnkA from two geographically distinct strains. Sequence comparison showed that despite a high degree of conservation, geographic polymorphisms could be detected. The localization of AnkA with condensed chromatin of infected cells suggests a role in modulating host gene transcription.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by grant AI41213-01 from the National Institutes of Allergy and Infectious Diseases.
We thank Joan Valentine, Phil Richter, Jeff Barlough, and Elfriede DeRock for excellent technical assistance. Partial nucleotide sequencing was performed by Midland Laboratory (Midland, Tex.).
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Division of Medical Microbiology, Department of Pathology, The Johns Hopkins Medical Institutions, Meyer B1-193, 600 North Wolfe St., Baltimore, MD 21201. Phone: (410) 955-5077. Fax: (410) 614-8087. E-mail: sdumler{at}jhmi.edu.
Editor: W. A. Petri Jr.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Aguero-Rosenfeld, M. E.,
H. W. Horowitz,
G. P. Wormser,
D. F. McKenna,
J. Nowakowski,
J. Munoz, and J. S. Dumler.
1996.
Human granulocytic ehrlichiosis (HGE): a case series from a single medical center in New York State.
Ann. Intern. Med.
125:904-908 |
| 2. |
Anderson, B. E.,
J. E. Dawson,
D. C. Jones, and K. H. Wilson.
1991.
Ehrlichia chaffeensis, a new species associated with human ehrlichiosis.
J. Clin. Microbiol.
29:2838-2842 |
| 3. |
Anderson, B. E.,
G. A. McDonald,
D. C. Jones, and R. L. Regnery.
1990.
A protective protein antigen of Rickettsia rickettsii has tandemly repeated, near-identical sequences.
Infect. Immun.
58:2760-2769 |
| 4. | Asanovich, K. M., J. S. Bakken, J. E. Madigan, M. Aguero-Rosenfeld, G. P. Wormser, and J. S. Dumler. 1997. Antigenic diversity of granulocytic Ehrlichia species isolates from humans in Wisconsin, New York, and a California horse. J. Infect. Dis. 176:1029-1034[Medline]. |
| 5. | Baeuerle, P. A., and D. Baltimore. 1996. NF-kappa B: ten years after. Cell 87:13-20[CrossRef][Medline]. |
| 6. |
Bakken, J. S.,
J. Krueth,
C. Wilson-Nordskog,
R. L. Tilden,
K. Asanovich, and J. S. Dumler.
1996.
Clinical and laboratory characteristics of human granulocytic ehrlichiosis.
JAMA
275:199-205 |
| 7. | Barlough, J. E., J. E. Madigan, E. DeRock, J. S. Dumler, and J. S. Bakken. 1995. Protection against Ehrlichia equi is conferred by prior infection with the human granulocytotropic ehrlichia (HGE agent). J. Clin. Microbiol. 33:3333-3334[Abstract]. |
| 8. | Beck, K. A., J. A. Buchanan, and W. J. Nelson. 1997. Golgi membrane skeleton: identification, localization and oligomerization of a 195-kDa ankyrin isoform associated with Golgi complex. J. Cell Sci. 110:1239-1249[Abstract]. |
| 9. |
Chen, S.-M.,
J. S. Dumler,
J. S. Bakken, and D. H. Walker.
1994.
Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease.
J. Clin. Microbiol.
32:589-595 |
| 10. | Dumler, J. S., K. M. Asanovich, J. S. Bakken, P. Richter, R. Kimsey, and J. E. Madigan. 1995. Serologic cross-reaction among Ehrlichia equi, Ehrlichia phagocytophila, and human granulocytic ehrlichia. J. Clin. Microbiol. 33:1098-1103[Abstract]. |
| 11. | Gilmore, R. D. 1993. Comparison of the rompA gene repeat regions of Rickettsiae reveals species-specific arrangements of individual repeating units. Gene 125:97-102[CrossRef][Medline]. |
| 12. |
Hoock, T. C.,
L. L. Peters, and S. E. Lux.
1997.
Isoforms of ankyrin-3 that lack the NH2-terminal repeats associated with mouse macrophage lysosomes.
J. Cell Biol.
136:1059-1070 |
| 13. | Hsieh, T.-C., M. Aguero-Rosenfeld, J. M. Wu, C. Ng, N. K. Papanikolou, S. A. Varde, I. Schwartz, J. G. Pizzolo, M. Melamed, H. W. Horowitz, R. B. Nadelman, and G. P. Wormser. 1997. Cellular changes and induction of apoptosis in human promyelocytic HL60 cells infected with the agent of human granulocytic ehrlichiosis (HGE). Biochem. Biophys. Res. Commun. 232:298-303[CrossRef][Medline]. |
| 14. |
Ijdo, J. W.,
W. Sun,
L. A. Magnarelli, and E. Fikrig.
1998.
Cloning of the gene encoding the 44-kilodalton antigen of the agent of human granulocytic ehrlichiosis and characterization of the humoral response.
Infect. Immun.
66:3264-3269 |
| 15. |
Lee, E., and Y. Rikihisa.
1997.
Anti-Ehrlichia chaffeensis antibody complexed with E. chaffeensis induces potent proinflammatory cytokine mRNA expression in human monocytes through sustained reduction of I B and activation of NF- B.
Infect. Immun.
65:2890-2897[Abstract].
|
| 16. | Madigan, J. E., P. J. Richter, R. B. Kimsey, J. E. Barlough, J. S. Bakken, and J. S. Dumler. 1995. Transmission and passage in horses of the agent of human granulocytic ehrlichiosis. J. Infect. Dis. 172:1141-1144[Medline]. |
| 17. |
Miskin, J. E.,
C. C. Abrams,
L. C. Goatley, and L. K. Dixon.
1998.
A viral mechanism for inhibition of the cellular phosphatase calcineurin.
Science
281:562-565 |
| 18. | Moffat, F. L., T. Han, Z.-M. Li, M. D. Peck, R. E. Falk, P. B. Spalding, W. Jy, Y. S. Ahn, A. J. Chu, and L. Y. W. Bourguignon. 1996. Involvement of CD44 and the cytoskeletal linker protein ankyrin in human neutrophil bacterial phagocytosis. J. Cell. Physiol. 168:638-647[CrossRef][Medline]. |
| 19. |
Murphy, C. I.,
J. R. Storey,
J. Recchia,
L. A. Doros-Richert,
C. Gingrich-Baker,
K. Munroe,
J. S. Bakken,
R. T. Coughlin, and G. A. Beltz.
1998.
Major antigenic proteins of the agent of human granulocytic ehrlichiosis are encoded by members of a multigene family.
Infect. Immun.
66:3711-3718 |
| 20. | Nakai, K., and M. Kanehisa. 1991. Expert system for predicting protein localization sites in gram-negative bacteria. Proteins 11:95-110[CrossRef][Medline]. |
| 21. | Peters, L. L., and S. E. Lux. 1993. Ankyrins: structure and function in normal cells and hereditary spherocytes. Semin. Hematol. 30:85-118[Medline]. |
| 22. |
Popov, V. L.,
V. C. Han,
S.-M. Chen,
J. S. Dumler,
H.-M. Feng,
T. G. Andreadis,
R. B. Tesh, and D. H. Walker.
1998.
Ultrastructural differentiation of the genogroups in the genus Ehrlichia.
J. Med. Microbiol.
47:235-251 |
| 23. |
Popov, V. L.,
S.-M. Chen,
H.-M. Feng, and D. H. Walker.
1995.
Ultrastructural variation of cultured Ehrlichia chaffeensis.
J. Med. Microbiol.
43:411-421 |
| 24. |
Storey, J. R.,
L. A. Doros-Richert,
C. Gingrich-Baker,
K. Munroe,
T. N. Mather,
R. T. Coughlin,
G. A. Beltz, and C. I. Murphy.
1998.
Molecular cloning and sequencing of three granulocytic Ehrlichia genes encoding high-molecular-weight immunoreactive proteins.
Infect. Immun.
66:1356-1363 |
| 25. | Sumner, J. W., W. L. Nicholson, and R. F. Massung. 1997. PCR amplification and comparison of nucleotide sequences from the groESL heat shock operon of Ehrlichia species. J. Clin. Microbiol. 35:2087-2092[Abstract]. |
| 26. | Walker, D. H., and J. S. Dumler. 1996. Emergence of ehrlichioses as human health problems. Emerg. Infect. Dis. 2:18-29[Medline]. |
| 27. | Yu, X. J., P. Crocquet-Valdes, and D. H. Walker. 1997. Cloning and sequencing of the gene for a 120-kDa immunodominant protein of Ehrlichia chaffeensis. Gene 184:149-54[CrossRef][Medline]. |
| 28. |
Zhi, N.,
Y. Rikihisa,
H. W. Horowitz, and G. P. Wormser.
1998.
Cloning and expression of the 44-kilodalton major outer membrane protein gene of the human granulocytic ehrlichiosis agent and application of the recombinant protein to serodiagnosis.
J. Clin. Microbiol.
36:1666-1673 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»